Enoxaparin Biosimilar Makes It Six For Sandoz Canada
Completed Negotiations With The pCPA For Public Reimbursement
Sandoz Canada has taken another “important step as we pursue our ambition to become the leading biosimilars and generics company” with the launch of biosimilar enoxaparin.
